Ocean Biomedical Inc (OCEA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access OCEA Annual Balance Sheets →
This page allows investors to track Ocean Biomedical Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Other Current Assets0.78
Prepaid Expense, Current AS0.72
Total Current Assets1.49
Long-term investments0.09
Other Assets, Noncurrent0.00
Restricted Cash Current0.78
Total Assets1.58
Liabilities
Accounts Payable, Current AC16.39
Accrued Liabilities, Current AC0.63
Derivative Liability, Current DE0.20
Loans Payable, Current NO9.35
Other Liabilities, Current0.00
Total Current Liabilities26.57
Total Long-term Debt0.00
Other liabilities, Noncurrent67.41
Fixed Maturity Consideration6.00
Backstop Put Option Liability61.41
Total Liabilities93.98
Stockholders' Equity
Additional Paid In Capital Common Stock121.38
Retained Earnings / Accumulated Deficit-213.78
Other Equity0.00
Common Stockholder's Equity-92.40
Total Stockholder's Equity-92.40
Liabilities & Stockholder's Equity1.58
4 historic quarters locked

Sign in to unlock the full Ocean Biomedical Inc balance sheet history.

About Ocean Biomedical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20250331)
  • Filed with the SEC: May 15, 2025
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001641172-25-011080

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.